Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1727952060;52061;52062 chr2:178609475;178609474;178609473chr2:179474202;179474201;179474200
N2AB1563847137;47138;47139 chr2:178609475;178609474;178609473chr2:179474202;179474201;179474200
N2A1471144356;44357;44358 chr2:178609475;178609474;178609473chr2:179474202;179474201;179474200
N2B821424865;24866;24867 chr2:178609475;178609474;178609473chr2:179474202;179474201;179474200
Novex-1833925240;25241;25242 chr2:178609475;178609474;178609473chr2:179474202;179474201;179474200
Novex-2840625441;25442;25443 chr2:178609475;178609474;178609473chr2:179474202;179474201;179474200
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: I
  • RefSeq wild type transcript codon: ATT
  • RefSeq wild type template codon: TAA
  • Domain: Ig-112
  • Domain position: 29
  • Structural Position: 46
  • Q(SASA): 0.156
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
I/T None None 0.722 D 0.712 0.667 0.839211880287 gnomAD-4.0.0 3.18798E-06 None None None None N None 0 0 None 0 0 None 0 0 5.72551E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
I/A 0.7337 likely_pathogenic 0.7566 pathogenic -2.086 Highly Destabilizing 0.775 D 0.67 neutral None None None None N
I/C 0.8705 likely_pathogenic 0.8713 pathogenic -1.292 Destabilizing 0.996 D 0.704 prob.neutral None None None None N
I/D 0.9912 likely_pathogenic 0.9919 pathogenic -1.652 Destabilizing 0.987 D 0.872 deleterious None None None None N
I/E 0.9647 likely_pathogenic 0.965 pathogenic -1.552 Destabilizing 0.961 D 0.866 deleterious None None None None N
I/F 0.5591 ambiguous 0.549 ambiguous -1.274 Destabilizing 0.82 D 0.672 neutral N 0.503794855 None None N
I/G 0.968 likely_pathogenic 0.9692 pathogenic -2.517 Highly Destabilizing 0.961 D 0.856 deleterious None None None None N
I/H 0.9604 likely_pathogenic 0.9602 pathogenic -1.673 Destabilizing 0.996 D 0.847 deleterious None None None None N
I/K 0.9072 likely_pathogenic 0.8986 pathogenic -1.577 Destabilizing 0.961 D 0.866 deleterious None None None None N
I/L 0.3034 likely_benign 0.2944 benign -0.916 Destabilizing 0.003 N 0.233 neutral N 0.502273918 None None N
I/M 0.2645 likely_benign 0.2666 benign -0.725 Destabilizing 0.901 D 0.645 neutral D 0.531306859 None None N
I/N 0.9051 likely_pathogenic 0.9176 pathogenic -1.547 Destabilizing 0.983 D 0.869 deleterious D 0.531813838 None None N
I/P 0.9635 likely_pathogenic 0.9598 pathogenic -1.279 Destabilizing 0.987 D 0.874 deleterious None None None None N
I/Q 0.9325 likely_pathogenic 0.9309 pathogenic -1.591 Destabilizing 0.987 D 0.885 deleterious None None None None N
I/R 0.8828 likely_pathogenic 0.8724 pathogenic -1.063 Destabilizing 0.961 D 0.869 deleterious None None None None N
I/S 0.8532 likely_pathogenic 0.878 pathogenic -2.235 Highly Destabilizing 0.949 D 0.793 deleterious N 0.513456093 None None N
I/T 0.7165 likely_pathogenic 0.7416 pathogenic -1.999 Destabilizing 0.722 D 0.712 prob.delet. D 0.531306859 None None N
I/V 0.0834 likely_benign 0.0808 benign -1.279 Destabilizing 0.034 N 0.149 neutral N 0.451222021 None None N
I/W 0.9794 likely_pathogenic 0.9766 pathogenic -1.44 Destabilizing 0.996 D 0.817 deleterious None None None None N
I/Y 0.9136 likely_pathogenic 0.9102 pathogenic -1.211 Destabilizing 0.961 D 0.719 prob.delet. None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.